Advertisement
J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vanloo, B.
Right arrow Articles by Rosseneu, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vanloo, B.
Right arrow Articles by Rosseneu, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 41, 752-761, May 2000
Copyright © 2000 by Lipid Research, Inc.


Original Article

Relationship between structure and biochemical phenotype of lecithin:cholesterol acyltransferase (LCAT) mutants causing fish-eye disease

Berlinda Vanlooa, Frank Peelmana, Kristof Deschuymerea, Josee Taveirnea, Annick Verheeb, Catherine Gouyettec, Christine Labeura, Joël Vandekerckhoveb, Jan Tavernierb, and Maryvonne Rosseneua
a Laboratory for Lipoprotein Chemistry, Department of Medical Protein Research, Faculty of Medicine, Department of Biochemistry, University of Gent, B-9000 Gent, Belgium
b Flanders Interuniversity Institute for Biotechnology, Department of Medical Protein Research, Faculty of Medicine, Department of Biochemistry, University of Gent, B-9000 Gent, Belgium
c Unite Chimie Organique, Institut Pasteur, Paris, France

Correspondence to: Maryvonne Rosseneu

In order to test the hypothesis that fish-eye disease (FED) is due to a deficient activation of lecithin:cholesterol acyltransferase (LCAT) by its co-factor apolipoprotein (apo) A-I, we overexpressed the natural mutants T123I, N131D, N391S, and other engineered mutants in Cos-1 cells. Esterase activity was measured on a monomeric phospholipid enelogue, phospholipase A2 activity was measured on reconstituted high density lipoprotein (HDL), and acyltransferase activity was measured both on rHDL and on low density lipoprotein (LDL). The natural FED mutants have decreased phospholipase A2 activity on rHDL, which accounts for the decreased acyltransferase activity previously reported. All mutants engineered at positions 131 and 391 had decreased esterase activity on a monomeric substrate and decreased acyltransferase activity on LDL. In contrast, mutations at position 123 preserved these activities and specifically decreased phospholipase A2 and acyltransferase activites on rHDL. Mutations of hydrophilic residues in amphipathic helices {alpha} 3;–4 and {alpha} His to an alanine did not affect the mutants' activity on rHDL. Based upon the 3D model built for human LCAT, we designed a new mutant F382A, which had a biochemical phenotype similar to the natural T123I FED mutant.

These data suggest that residues T123 and F382, located N-terminal of helices {alpha} 3–4 and {alpha} His, contribute specifically to the interaction of LCAT with HDL and possibly with its co-factor apoA-I. Residues N131 and N391 seem critical for the optimal orientation of the two amphipathic helices necessary for the recognition of a lipoprotein substrate by the enzyme.—Vanloo, B., F. Peelman, K. Deschuymere, J. Taveirne, A. Verhee, C. Gouyette, C. Labeur, J. Vandekerckhove, J. Tavernier, and M. Rosseneu. Relationship between structure and biochemical phenotype of lecithin:cholesterol acyltransferase (LCAT) mutants causing fish-eye disease. J. Lipid Res. 2000. 41: 752;–761.

Supplementary key words: cholesterol, phospholipid, enzyme, lipase, HDL, LDL, esterase, acyltransferase, phospholipase A2, apolipoprotein A-I


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
F. Peelman, B. Vanloo, J.-L. Verschelde, C. Labeur, H. Caster, J. Taveirne, A. Verhee, N. Duverger, J. Vandekerckhove, J. Tavernier, et al.
Effect of mutations of N- and C-terminal charged residues on the activity of LCAT
J. Lipid Res., April 1, 2001; 42(4): 471 - 479.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
S. Roosbeek, B. Vanloo, N. Duverger, H. Caster, J. Breyne, I. De Beun, H. Patel, J. Vandekerckhove, C. Shoulders, M. Rosseneu, et al.
Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase
J. Lipid Res., January 1, 2001; 42(1): 31 - 40.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. Kosman and A. Jonas
Deletion of Specific Glycan Chains Affects Differentially the Stability, Local Structures, and Activity of Lecithin-cholesterol Acyltransferase
J. Biol. Chem., September 28, 2001; 276(40): 37230 - 37236.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement